IDARUCIZUMAB vs IDELALISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
IDARUCIZUMAB vs IDELALISIB: Safety Overview
| Metric | IDARUCIZUMAB | IDELALISIB |
|---|---|---|
| Total FAERS Reports | 1,562 | 6,862 |
| Deaths Reported | 1,014 | 1,548 |
| Death Rate | 64.9% | 22.6% |
| Hospitalizations | 570 | 2,962 |
| Average Patient Age | 77.6 yrs | 70.0 yrs |
| % Female Patients | 42.7% | 38.4% |
| FDA Approval Date | N/A | Jul 23, 2014 |
| Manufacturer | Boehringer Ingelheim Pharmaceuticals,... | Gilead Sciences, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |